Feng, Shouya
Wierzbowski, Matthew C. https://orcid.org/0009-0005-9749-627X
Hrovat-Schaale, Katja https://orcid.org/0000-0002-0398-5015
Dumortier, Andreas https://orcid.org/0009-0004-6716-9983
Zhang, Yaoyuan
Zyulina, Maria
Baker, Paul J. https://orcid.org/0000-0002-3642-2366
Reygaerts, Thomas
Steiner, Annemarie
De Nardo, Dominic https://orcid.org/0000-0002-7045-4695
Narayanan, Dhanya Lakshmi
Milhavet, Florian
Pinzon-Charry, Alberto
Arostegui, Juan Ignacio https://orcid.org/0000-0003-4757-504X
Khubchandani, Raju P.
Geyer, Matthias https://orcid.org/0000-0002-7718-5002
Boursier, Guilaine https://orcid.org/0000-0002-2903-3135
Masters, Seth L. https://orcid.org/0000-0003-4763-576X
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (GNT2008699)
European Joint Programme on Rare Diseases
Jack Brockhoff Foundation (5252)
Monash University FMNHS Senior Postdoctoral Fellowship.
Deutsche Forschungsgemeinschaft (EXC2151-390873048, GRK 2168)
European Research Council (ERC Advanced Grant NalpACT).
Article History
Received: 27 February 2024
Accepted: 13 January 2025
First Online: 10 February 2025
Competing interests
: S.L.M. is the Vice President of Discovery Biology of NRG Therapeutics and scientific advisor for Odyssey Therapeutics. M.G. is a scientific advisor to BioAge Labs. The other authors declare no competing interests.